Head of Russia’s Nuclear, Chemical, and Biological Protection Forces, Lieutenant General Igor Kirillov has claimed that the U.S. is expanding its biological military presence across Africa.
According to Kirillov, Africa is a new zone of interest for the U.S. Defense Department and related agencies.
The general mentioned the presence of Pentagon contractors in several African countries, including Kenya, Nigeria, the Democratic Republic of the Congo, Sierra Leone, Cameroon, Uganda, and South Africa.
“Washington uses outside actors to hide the objectives of research. These are contracting and intermediary organizations (Metabiota, Quicksilver, EkoHealth Alliance, more than 20 companies) and businesses of the so-called Big Pharma,” Kirillov claimed.
Russia has documents confirming the rapid expansion of the U.S. biological warfare presence in the African continent, he added.
Kirillov cited several examples of alleged U.S. activities, stating that “in October 2023, staff of the U.S. Army Medical Research Institute of Infectious Diseases conducted a large-scale survey of hantavirus samples from bats in Kenya’s natural hotspots.
A year ago, U.S. military biologists studied the effects of anti-malarial drugs on local populations.
“In January 2024, U.S. officials from the Defense Department, the State Department, and the U.S. Department of Health and Human Services met with the heads of the Centers for Disease Control and Prevention in Africa to discuss the continent’s prospects for developing laboratory capabilities,” the general said.
At the end of last year, Kirillov said Russia had obtained documents proving that the U.S. had conducted research on bioweapon components and hazardous pathogens in Ukraine.
Oganisers and participants in illicit biological-military activities within the selected African include servicemen of the Walter Reed Army Institute of Research, staff from the U.S. Defense Threat Reduction Agency (DTRA) regional offices, the Centers for Disease Control and Prevention in Africa, and representatives from the Global Fund to Fight AIDS, Tuberculosis and Malaria.
These include:
Alexis Robinson is the U.S. Defense Threat Reduction Agency Attaché for South, Central and East Africa, who has been involved in training local specialists in DTRA operations in exchange for intelligence of interest to the Pentagon.
Helina Meri and Mark Breda are regional directors of the Walter Reed Army Institute of Research in Nigeria and Tanzania. They acted as organisers of the collection of biomaterial from the local population for the benefit of the U.S. military, as well as the testing of unlicensed drugs.
Jane Wachira is the chief executive officer of the Kenya Veterinary Vaccines Production Institute. She facilitated unrestricted access for U.S. specialists to Kenya’s collection of highly dangerous pathogens.
John Nikoimo is the head of the Special Operations Command in Kenya. He supervised the DTRA programme to enhance the capability of Kenya’s defence forces to handle chemical, biological, radiological and nuclear substances.
As a result of the analysis of the documentation received, more than 30 persons were identified, including officials of government bodies, employees of intermediary organisations and private companies.
